Global Biotech Ingredients Market Size Study, by Type (Active Pharmaceutical Ingredients, Biosimilars), by Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, Blood Factors), by Expressio

Global Biotech Ingredients Market Size Study, by Type (Active Pharmaceutical Ingredients, Biosimilars), by Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, Blood Factors), by Expression Systems (Mammalian, Microbial, Yeast, Plant, Insect), and Regional Forecasts 2022-2032

Global Biotech Ingredients Market was valued at approximately USD 59.10 billion in 2023 and is expected to grow at a CAGR of 4.81% during the forecast period of 2024 to 2032. Biotech ingredients are structurally similar to naturally occurring compounds and are produced using advanced biotechnological methods such as genetic engineering, recombinant DNA technology, and hybridoma technology. These ingredients are increasingly being adopted in various sectors including personal care, aromatics, and herbal products, significantly contributing to the growth of the biotech ingredients market.

The Global Biotech Ingredients Market is primarily driven by the rising consumer awareness of the adverse effects associated with synthetic products. This shift in consumer preference towards natural and biotech-derived alternatives, particularly in the pharmaceutical and personal care sectors, is fueling the demand for biotech ingredients. Additionally, the increasing utilization of these ingredients in the food and beverage industry is further bolstering market growth. However, the market faces challenges such as the limited availability of raw materials, which could potentially hinder the growth trajectory.

The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, Europe dominated the biotech ingredients market supported by its large consumer base, robust end-use sectors, and favorable governmental policies. Furthermore, the Asia-Pacific region is anticipated to witness the fastest growth during the forecast period, driven by the presence of leading biopharmaceutical companies in countries such as China, India, Japan, and South Korea, along with the region's rich heritage in herbal medicine.

Major market players included in this report are:
Teva Pharmaceutical Industries Ltd.
Mylan, Inc.
Boehringer Ingelheim
Sanofi
AbbVie
Eli Lilly and Company
AstraZeneca plc
Pfizer Inc.
Novartis International AG
Merck & Co.

The detailed segments and sub-segment of the market are explained below:
By Type:
• Active Pharmaceutical Ingredients
• Biosimilars
By Product:
• Monoclonal Antibodies
• Vaccines
• Hormones and Growth Factors
• Cytokines
• Fusion Proteins
• Therapeutic Enzymes
• Blood Factors
By Expression Systems:
• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Plant Expression Systems
• Insect Expression Systems
By Region:
North America:
• U.S.
• Canada
Europe:
• UK
• Germany
• France
• Spain
• Italy
• ROE (Rest of Europe)
Asia Pacific:
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC (Rest of Asia Pacific)
Latin America:
• Brazil
• Mexico
• RoLA (Rest of Latin America)
Middle East & Africa:
• Saudi Arabia
• South Africa
• RoMEA (Rest of Middle East & Africa)
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.